Glenmark Hints At Emerging Markets Cutback Amid Strong Q3

Glenmark Pharmaceuticals Limited has reported strong growth in the third quarter ended December 2015, despite the challenges in certain emerging markets, from where it sees "diminishing" contribution to revenues here on.